Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.64B
Close$
$62.50
30.6% upsideKiniksa Pharmaceuticals International Plc. Target Price Details
Target Price by Analysts
30.6% upsideKiniksa Pharmaceuticals International Plc. Target Price Details$-4.53
109.5% downside
Current Fair Value
109.5% downsideOvervalued by 109.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.64 Billion |
|---|---|
| Enterprise Value | $3.46 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.8 |
| Beta | 0.17 |
| Outstanding Shares | 76,516,535 |
Return
| Return on Equity | 12.06% |
|---|---|
| Return on Assets | 8.85% |
| Return on Invested Capital | 14.52% |
Valuation & Multiples
| P/E Ratio | 50.67 |
|---|---|
| PEG | 30.79 |
| Price to Sales | 5.32 |
| Price to Book Ratio | 6.84 |
| Enterprise Value to Revenue | 4.58 |
| Enterprise Value to EBIT | 35.6 |
| Enterprise Value to Net Income | 47 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 5, 2026
EPS Estimate
$0.18
Average shareholder expectationRevenue Estimate
$207.12 M
Average shareholder expectationNext Earnings Call
Expected Date
July 28, 2026
EPS Estimate
$0.30
Average shareholder expectationRevenue Estimate
$226.56 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0220▼ 2.12% |
|---|---|
| Total Calls | 1,066,700▼ 31.84% |
| Total Puts | 23,500▼ 65.24% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 61.19%▲ 2.83% |
|---|---|
| Total Invested | $2.18B▲ 23.15% |
| Investors Holding | 233▲ 6.00% |
ESG Score
No data